Viewing StudyNCT00072566



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00072566
Status: COMPLETED
Last Update Posted: 2015-05-12
First Post: 2003-11-04

Brief Title: Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor:
Organization: National Cancer Institute NCI